You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pralatrexate

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral T Cell Lymphoma Trial in Harlingen (Belinostat Injection, Pralatrexate Injection, CHOP)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Belinostat Injection
  • +3 more
  • Harlingen, Texas
    Valley Cancer Associates
Oct 16, 2023

Lymphoma, T-Cell Trial in Charlottesville (Durvalumab, Pralatrexate, Romidepsin)

Recruiting
  • Lymphoma, T-Cell
  • Charlottesville, Virginia
    University of Virginia
Mar 16, 2022

Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Recurrent Anaplastic Large Cell Lymphoma

Recruiting
  • Anaplastic Large Cell Lymphoma
  • +19 more
  • Pembrolizumab
  • Pralatrexate
  • Duarte, California
  • +2 more
Aug 15, 2022

Lymphoma, B-Cell Trial in United States (Pralatrexate, Vitamin B12, Folic Acid)

Completed
Has Results
  • Lymphoma, B-Cell
  • Pralatrexate
  • +2 more
  • Beverly Hills, California
  • +10 more
Oct 7, 2021

Peripheral T-Cell Lymphoma (PTCL) Trial in United States (Pralatrexate Injection)

Completed
  • Peripheral T-Cell Lymphoma (PTCL)
  • Pralatrexate Injection
  • Rochester, Minnesota
  • +3 more
Jul 23, 2021

PTCL Trial in Long Beach, New Haven, Charlottesville (Azacytidine, Romidepsin, Belinostat)

Recruiting
  • PTCL
  • Long Beach, California
  • +2 more
Mar 1, 2022

Peripheral T-cell Lymphoma Trial in Worldwide (Pralatrexate Injection)

Terminated
Has Results
  • Peripheral T-cell Lymphoma
  • Pralatrexate Injection
  • Novi, Michigan
  • +54 more
Nov 18, 2021

Lymphoma Trial in New York (pralatrexate)

Completed
Has Results
  • Lymphoma
  • pralatrexate
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 20, 2021

NSCLC Trial in Worldwide (Pralatrexate, Erlotinib, Vitamin B12)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Pralatrexate
  • +3 more
  • Bakersfield, California
  • +46 more
Feb 8, 2021

Lymphoid Malignancies, Multiple Myeloma, Lymphoma Trial in Boston, New York (Pralatrexate, Romidepsin)

Unknown status
  • Lymphoid Malignancies
  • +4 more
  • Boston, Massachusetts
  • +1 more
Feb 6, 2020

Cutaneous T-cell Lymphoma Trial in United States (Vitamin B12, Folic Acid, Pralatrexate)

Completed
  • Cutaneous T-cell Lymphoma
  • Vitamin B12
  • +2 more
  • Duarte, California
  • +9 more
Jan 2, 2020

Breast Cancer, Breast Tumors, Tumors, Breast Trial in Worldwide (Pralatrexate Injection, Vitamin B12, Folic Acid)

Completed
Has Results
  • Breast Cancer
  • +4 more
  • Pralatrexate Injection
  • +2 more
  • Portland, Oregon
  • +13 more
Jan 2, 2020

Non Hodgkin's Lymphoma Trial (Fusilev, Folotyn)

Withdrawn
  • Non Hodgkin's Lymphoma
  • (no location specified)
Jan 21, 2020

NSCLC Trial (Folotyn, Fusilev)

Withdrawn
  • Non-Small Cell Lung Cancer
  • (no location specified)
Jan 21, 2020

Carcinoma, Transitional Cell, Bladder Cancer, Bladder Tumor Trial in Worldwide (Pralatrexate Injection, Vitamin B12, Folic Acid)

Completed
Has Results
  • Carcinoma, Transitional Cell
  • +2 more
  • Pralatrexate Injection
  • +2 more
  • Tucson, Arizona
  • +18 more
Dec 10, 2019

Refractory Peripheral T-Cell Lymphoma, Relapsed T-Cell Lymphoma Trial in Beijing (pralatrexate, Vitamin B12 and folic acid)

Completed
Has Results
  • Refractory Peripheral T-Cell Lymphoma
  • Relapsed T-Cell Lymphoma
  • pralatrexate
  • Vitamin B12 and folic acid
  • Beijing, China
    Beijing Cancer Hospital
Sep 17, 2019

Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States

Completed
Has Results
  • Relapsed or Refractory Lymphoproliferative Malignancies
  • +4 more
  • Pralatrexate Injection
  • +3 more
  • Los Angeles, California
  • +14 more
Dec 27, 2019

Peripheral T-cell Lymphoma Trial in Worldwide (Pralatrexate Injection)

Completed
Has Results
  • Peripheral T-cell Lymphoma
  • Pralatrexate Injection
  • Duarte, California
  • +31 more
Dec 9, 2019

Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma Trial in Duarte, Wichita, Seattle (Folotyn and

Completed
  • Relapsed Peripheral T-Cell Lymphoma
  • Refractory Peripheral T-Cell Lymphoma
  • Folotyn and Leucovorin
  • +2 more
  • Duarte, California
  • +2 more
Nov 18, 2019

NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,

Recruiting
  • NK-Cell Lymphoma
  • +2 more
  • San Francisco, California
  • +1 more
Sep 1, 2021

Lymphoma, T-Cell, Peripheral Trial (Romidepsin, Pralatrexate)

Withdrawn
  • Lymphoma, T-Cell, Peripheral
  • (no location specified)
Dec 17, 2018

Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

Recruiting
  • Cutaneous T Cell Lymphoma
  • Peripheral T Cell Lymphoma
  • Microdevices
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 16, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

Completed
Has Results
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Chemosensitivity Assay
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 29, 2022

Solid Tumor Trial in Omaha (drug, other, genetic)

Completed
Has Results
  • Unspecified Adult Solid Tumor, Protocol Specific
  • pralatrexate
  • +9 more
  • Omaha, Nebraska
    UNMC Eppley Cancer Center at the University of Nebraska Medical
Jul 13, 2018

Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma Trial in United States (drug,

Completed
Has Results
  • Anaplastic Large Cell Lymphoma
  • +3 more
  • Scottsdale, Arizona
  • +8 more
May 23, 2018